Lunai Bioworks annual free cash flow
2018
2019
2020
2021
2022
2023
2024
Lunai Bioworks Free Cash Flow (FCF) History (LNAI)
Lunai Bioworks reported −$11.0M in free cash flow for fiscal 2024, an increase of $762,463 from the previous fiscal year.
View full Lunai Bioworks company overviewLunai Bioworks free cash flow by year
| Fiscal year | Period ended | Free cash flow | Change | Growth | FCF margin |
|---|---|---|---|---|---|
| 2024 | 2024-06-30 | −$11.0M | $762,463 | — | — |
| 2023 | 2023-06-30 | −$11.8M | $3.9M | — | — |
| 2022 | 2022-06-30 | −$15.7M | $4.9M | — | — |
| 2021 | 2021-06-30 | −$20.7M | −$10.0M | — | — |
| 2020 | 2020-06-30 | −$10.6M | −$1.4M | — | — |
| 2019 | 2019-06-30 | −$9.2M | −$4.9M | — | — |
| 2018 | 2018-06-30 | −$4.4M | — | — | — |
Lunai Bioworks quarterly free cash flow
Q1.14
Q1.19
Q2.19
Q3.19
Q4.19
Q1.20
Q2.20
Q3.20
Q4.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q3.23
Q3.24
Q3.26
| Fiscal quarter | Period ended | Free cash flow | Change | YoY growth | FCF margin |
|---|---|---|---|---|---|
| Q3 2026 | 2026-03-31 | −$1.0M | $1.8M | — | −4903.33% |
| Q3 2024 | 2024-03-31 | −$2.6M | $2.0M | — | — |
| Q3 2023 | 2023-03-31 | −$3.3M | $2.0M | — | — |
| Q4 2022 | 2022-06-30 | −$3.1M | $10.0M | — | — |
| Q3 2022 | 2022-03-31 | −$2.8M | −$453,850 | — | — |
| Q2 2022 | 2021-12-31 | −$4.6M | −$2.1M | — | — |
| Q1 2022 | 2021-09-30 | −$5.3M | −$2.5M | — | — |
| Q4 2021 | 2021-06-30 | −$13.1M | −$10.8M | — | — |
| Q3 2021 | 2021-03-31 | −$2.3M | $1.5M | — | — |
| Q2 2021 | 2020-12-31 | −$2.5M | $132,095 | — | — |
| Q1 2021 | 2020-09-30 | −$2.8M | −$886,462 | — | — |
| Q4 2020 | 2020-06-30 | −$2.3M | −$20,462 | — | — |
| Q3 2020 | 2020-03-31 | −$3.9M | −$1.0M | — | — |
| Q2 2020 | 2019-12-31 | −$2.6M | −$552,431 | — | — |
| Q1 2020 | 2019-09-30 | −$1.9M | $235,707 | — | — |
| Q4 2019 | 2019-06-30 | −$2.2M | −$1.8M | — | — |
| Q3 2019 | 2019-03-31 | −$2.8M | — | — | — |
| Q2 2019 | 2018-12-31 | −$2.1M | — | — | — |
| Q1 2019 | 2018-09-30 | −$2.1M | — | — | — |
| Q1 2014 | 2014-03-31 | −$479,244 | — | — | — |
Lunai Bioworks free cash flow growth trends
Over the last five reported fiscal years, free cash flow declined from −$9.2M to −$11.0M, a net decrease of $1.8M. Lunai Bioworks's latest reported quarter, Q3 2026, generated −$1.0M in free cash flow, an increase of $1.8M year over year.
About the metric
What free cash flow means
Free cash flow is the cash a company generates from operations after capital expenditures. Positive FCF can fund dividends, buybacks, debt repayment, or reinvestment; negative FCF means capital spending exceeded operating cash flow for that period.
Calculation and source
How free cash flow is calculated
TickerStat calculates free cash flow as SEC-reported operating cash flow minus capital expenditures. FCF margin equals free cash flow divided by revenue. Fiscal periods can differ from calendar years, so the tables include exact period-end dates.
Review Lunai Bioworks filings at SEC.gov ↗